Patent Applications with Amino Acid Claims
The applications listed below recite at least one amino acid sequence in the claims that has a high degree of similarity to an influenza peptide sequence. For each application, we show the sequences that are similar to or identical to an influenza sequence. Although most all of the applications recite multiple sequences in the published claims, there is generally only one or a few claims in prosecution. The last column shows the non-U.S. jurisdictions where related applications have been filed. No information is provided here regarding the status of these applications.
This set of applications was identified using blastp. The criteria for inclusion in this table is that the patent claim sequences were at least 80% identical to an influenza peptide sequence.
Of the 57 applications in the table below, 40 are assigned to corporations and 17 are assigned to non-profit organizations.
| Application No. | Assignee | Title | Sequence IDs in Claims Similar to Influenza | Other Jurisdictions with Family Members |
|---|---|---|---|---|
| 20050208066 | Academia Sinica | Recombinant baculovirus and virus-like particle | 10 | – |
| 20070224594 | Arbor Vita Corporation | Detection of influenza virus | 4 | Australia, Canada, Europe |
| 20030099670 | Artemis Pharmaceuticals GMBH | Influenza viruses with enhanced transcriptional and replicational capacities | 25,27,29,31,33,35,37,39,41,43,45,47 | Australia, Europe, Japan |
| 20070026009 | Inventors:Samuel Bogoch et al. | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds | 15 | Australia, Brazil, Canada, China, Europe, Israel, Japan, Korea, New Zealand |
| 20050059107 | Comissariat A L’Energie Atomique | Method of selecting hla-dp4 ligands and the applications thereof | 5 | Australia, Canada, Europe, France |
| 20020081680 | Corixa Corp. | Compositions and methods for the therapy and diagnosis of prostate cancer | 973 | Austria, Australia, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, United Kingdom, Hungary, Israel, Japan, Korea, Mexico, Norway, New Zealand, Poland, Russian Federation, Turkey, South Africa |
| 20020192763 | Corixa Corp. | Compositions and methods for the therapy and diagnosis of prostate cancer | 973 | Austria, Australia, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, United Kingdom, Hungary, Israel, Japan, Korea, Mexico, Norway, New Zealand, Poland, Russian Federation, Turkey, Taiwan, South Africa |
| 20070253981 | Cornell Research Foundation | Canine Influenza Virus | 2 | World |
| 20040180058 | Curelab, Inc. | Vaccine compositions and methods | 3,4 | Australia, Canada, Europe, Japan |
| 20070048287 | Cytos Biotechnology AG | Molecular antigen array | 213 | Australia, Brazil, Canada, China, Europe, Israel, Japan, Korea |
| 20070286871 | Diversa Corporation | Vaccines | 6 | Canada, United Kingdom, Norway |
| 20040268442 | Dow AgroSciences LLC | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production | 4 | Australia, Brazil, Canada, China, Europe, Japan, Korea |
| 20060222664 | Dow AgroSciences LLC | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production | 4 | Australia, Brazil, Canada, China, Europe, Japan, Korea |
| 20070107086 | Dow AgroSciences LLC | Preparation of vaccine master cell lines using recombinant plant suspension cultures | 4 | Argentina, World |
| 20070275014 | Fraunhofer U.S.A. Inc. | Influenza antigens, vaccine compositions, and related methods | 1,2,3,4,7,8,11,12,13,16,18,20,24 | Australia, Canada, China, Europe |
| 20060188469 | General Electric Company | Vaccine delivery compositions and methods of use | 9 | Austria, Australia, Canada, China, Germany, Europe, Spain, Japan, Korea |
| 20040202673 | Genesis Biotech, Inc. | Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes | 1 | China |
| 20050106563 | Genesis Biotech, Inc. | Epitope profiles of SARS coronavirus | 5,6 | – |
| 20070042001 | Hawaii Biotech, Inc. | Influenza recombinant subunit vaccine | 1,2,3,4,5,6,7 | World |
| 20070042002 | Hawaii Biotech, Inc. | Influenza recombinant subunit vaccine | 1,2,3,4,5,6,7,8,9,10,11 | World |
| 20080008725 | Hawaii Biotech, Inc. | Influenza recombinant subunit vaccine | 1,2,3,4,5,6,7,8,9,10 | World |
| 20070092536 | Heska Corporation | Cold-adapted equine influenza viruses | 6,9,14,22,25,28,33,37,40,43,46,49,54,62,64,67,69,72,77,85,88,96,99,101,103,105,107,109,111,112,114,116,118,120,122,124,126,128,130 | Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan |
| 20070172494 | Heska Corporation | Cold-adapted equine influenza viruses | 17,24 | Australia, Brazil, Canada, China, Germany, Europe, Spain, Japan, Korea |
| 20070196388 | Heska Corporation | Cold-adapted equine influenza viruses | 2,5,8,14,17,20,24 | Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan |
| 20040137015 | The University of Pittsburgh | Cold-adapted equine influenza viruses | 2,5,8,11,14,17,20,24,45,48,51,55,58,63,66,69,77,81,86,89,92,95,104,107 | Austria, Australia, Canada, Germany, Denmark, Europe, Spain, Japan |
| 20030099634 | IDM Pharma, Inc. | Compositions and methods for eliciting CTL immunity | 99 | Austria, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Germany, Denmark, Europe, Spain, Finland, Finland, Greece, Hungary, Hungary, Israel, Japan, Mexico, Norway, New Zealand, OAPI, Portugal, Russian Federation, Singapore, Slovakia, South Africa |
| 20060293262 | Immune Disease Institute, Inc. | Inhibition of gene expression using RNA interfering agents | 28 | Australia, Europe, Japan |
| 20030108561 | Innogenetics N.V. | Core-glycosylated HCV envelope proteins | 82 | ARIPO, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Europe, Croatia, Hungary, Israel, Japan, Mexico, New Zealand, Poland, Russian Federation, Slovakia, Yugoslavia, South Africa |
| 20030152940 | Innogenetics N.V. | Constructs and methods for expression of recombinant HCV envelope proteins | 82 | ARIPO, Australia, Bulgaria, Brazil, Canada, China, Czech Republic, Europe, Croatia, Hungary, Israel, Japan, Mexico, New Zealand, Poland, Russian Federation, Slovakia, Yugoslavia, South Africa |
| 20080008683 | Institut Gustave Rjoussy, Centre National de la Recherche Scientifique, and Universite Paris | Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins | 36,72 | Australia, Brazil, Canada, China, Europe, Japan |
| 20070098742 | Iowa State University Research Foundation | Canine influenza virus and related compositions and methods of use | 2,4,6,8,10,12,14,16 | Argentina, World |
| 20030219442 | Kirin Beer | Human monoclonal antibodies to influenza M2 protein and methods of making and using same | 1,2,3,4,5,6,7,8 | Australia, Canada, China, Europe, Japan |
| 20050170334 | Kirin Pharma Kabushiki Kaisha | Human monoclonal antibodies to influenza M2 protein and methods of making and using same | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,24 | Australia, Canada, China, Europe, Japan |
| 20050042229 | MedImmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants | 35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68 | Canada, Europe |
| 20060008473 | MedImmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants | 11,12,13,14,15,16,17,18,19,20 | Australia, Canada, Europe, Japan |
| 20070160622 | MediVas | Method for assembling a polymer-biologic delivery composition | 11,12,13,14,16 | Austria, Australia, Canada, China, Germany, Europe, Spain, Japan, Korea |
| 20040223976 | Merck & Co. Inc | Influenza virus vaccine | 1,2,10,39,59,60,61,62,126,127,128,129,130,131,132,133,1,135,136,137,138,139,143,144,145,146,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168 | Australia, Brazil, Canada, China, Europe, Japan, Korea, Mexico, Norway, Russian Federation, South Africa |
| 20060018903 | Merck Patent GMBH | TNF alpha-binding polypeptide compositions and methods | 21 | Brazil, Canada, China, Europe, Hungary, Japan, Korea, Mexico, Poland, Russian Federation, South Africa |
| 20080003203 | National Tsing Hua University | Pseudotyped baculovirus to stimulate immunogenicity against avian influenza | 1 | – |
| 20070184526 | Novavax, Inc. | Functional influenza virus like particles (VLPs) | 43 | Australia, Brazil, Canada, China, Europe, Japan, Korea, Mexico, Russian Federation, Singapore |
| 20030175285 | PF Medicament | Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of a physiologically acceptable strong acid | 189,527,529 | Australia, Brazil, Canada, China, Europe, France, Japan, Mexico, South Africa |
| 20080032921 | Pharmexa Inc. | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | 5,6,7,8,186 | – |
| 20050234222 | Photobiotics Ltd. | Conjugate | 6 | Canada, Europe, United Kingdom, Japan |
| 20040006022 | President and Fellows of Harvard College | Synthetic peptides and methods of use for autoimmune disease therapies | 1 | Australia, Canada, Europe, Hungary, Israel, Japan, Norway, New Zealand, South Africa |
| 20020165176 | Powerject Vaccines | Nucleic acid immunization | 1,2,3 | Australia, Europe |
| 20070066534 | Queensland Institute | Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes | 1,5,7,18,107,108,111,112 | Australia, Brazil, Canada, China, Europe, Japan, Korea |
| 20070160631 | Queensland Institute | Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes | 1,3,4 | Australia, Brazil, Canada, China, Europe, Japan, Korea |
| 20060222657 | The Regents of the University of California | Polypeptide transduction and fusogenic peptides | 2,3 | Australia, Canada, Europe |
| 20050191318 | Research Development Foundation | DNA immunocontraceptive vaccines and uses thereof | 15 | – |
| 20030148928 | Ribozyme Pharmaceuticals, Inc. | Enzymatic nucleic acid peptide conjugates | 19 | Australia |
| 20030157118 | Smithkline Beecham Biologicals | Tumour-specific animal proteins | 10 | Australia, Brazil, Canada, China, Czech Republic, Europe, United Kingdom, Hungary, Israel, Japan, Mexico, Norway, New Zealand, Poland, South Africa |
| 20060280754 | Tulane Educational Fund | Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins | 4 | Australia, Brazil, Canada, Europe, Japan |
| 20050074813 | U.S. Army | Model for testing immunogenicity of peptides | 1 | ARIPO, Australia, Brazil, Canada, China, Europe, Japan, New Zealand |
| 20060024670 | Vical Inc. | Influenza virus vaccine composition and methods of use | 76,78 | Australia, Canada, Europe, Japan |
| 20060153871 | Wisconsin Alumni Research Foundation | H3 equine influenza A virus | 1,2,3,4,5,6,7,8,17,18 | – |
| 20070059806 | Yeda Research and Development | Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection | 1,13,14,15 | Australia, Canada, Europe, Japan, Korea, Mexico, New Zealand, Poland, Russian Federation, South Africa |
| 20070122424 | Yeda Research and Development | Peptide-Based Vaccine for Influenza | 1,2,3,4,5 | Australia, Brazil, Canada, Europe, Israel, Japan, New Zealand |